"We developed this antibody and got to proof of concept in six months. Usually, that's more than six years," Eli Lilly CEO Dave Ricks said on CNBC's "Mad Money."
from US Top News and Analysis https://ift.tt/3cioxem
https://ift.tt/eA8V8J
from US Top News and Analysis https://ift.tt/3cioxem
https://ift.tt/eA8V8J
Comments
Post a Comment